Exelon Corp S-4, filed Aug 3, 2022
Exelon Corp (EXC)
UNDER
THE SECURITIES ACT OF 1933
| |
Pennsylvania
(State or other jurisdiction of incorporation
or organization) |
| |
4931
(Primary Standard Industrial
Classification Code Number) |
| |
23-2990190
(I.R.S. Employer Identification No.)
|
|
P.O. Box 805379
Chicago, Illinois 60680-5379
(800) 483-3220
Senior Executive Vice President and Chief Financial Officer
Exelon Corporation
10 South Dearborn Street
P.O. Box 805379
Chicago, Illinois 60603
800-483-3220
| |
Carter C. Culver, Esquire
Senior Vice President and Deputy General Counsel Exelon Corporation 10 South Dearborn Street P.O. Box 805379 Chicago, Illinois 60603 800-483-3220 |
| |
Patrick R. Gillard, Esquire
Ballard Spahr LLP 1735 Market Street, 51st Floor Philadelphia, Pennsylvania 19103 215-665-8500 |
|
| | Large accelerated filer ☒ | | | Accelerated filer ☐ | | | ||
| |
Non-accelerated filer ☐ (do not check if a smaller reporting company)
|
| | Smaller reporting company ☐ | | | ||
| | | | | Emerging growth company ☐ | | | | |
| | | | | | ii | | | |
| | | | | | ii | | | |
| | | | | | ii | | | |
| | | | | | 1 | | | |
| | | | | | 10 | | | |
| | | | | | 12 | | | |
| | | | | | 13 | | | |
| | | | | | 14 | | | |
| | | | | | 23 | | | |
| | | | | | 32 | | | |
| | | | | | 38 | | | |
| | | | | | 40 | | | |
| | | | | | 40 | | |
Attn: Investor Relations
10 South Dearborn Street — 54th Floor
P.O. Box 805398
Chicago, IL 60680-5398
| | | |
For the Year Ended December 31,
|
| |
For the Six Months
Ended June 30, |
| ||||||||||||||||||
| | | |
2021
|
| |
2020
|
| |
2019
|
| |
2022
|
| ||||||||||||
| | | |
($ in millions)
|
| |||||||||||||||||||||
| Statement of Operations Data | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Total Operating revenues
|
| | | $ | 17,938 | | | | | $ | 16,663 | | | | | $ | 16,725 | | | | | $ | 9,566 | | |
|
Operating income
|
| | | | 2,682 | | | | | | 2,191 | | | | | | 2,656 | | | | | | 1,593 | | |
|
Net income from continuing operations
|
| | | | 1,616 | | | | | | 1,099 | | | | | | 1,486 | | | | | | 946 | | |
| Cash Flow Data | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Net cash flows provided by operating activities
|
| | | | 3,012 | | | | | | 4,235 | | | | | | 6,659 | | | | | | 3,240 | | |
|
Net cash flows used in investing activities
|
| | | | (3,317) | | | | | | (4,336) | | | | | | (7,260) | | | | | | (3,346) | | |
|
Net cash flows provided by (used in) financing activities.
|
| | | | 758 | | | | | | 145 | | | | | | (58) | | | | | | 323 | | |
| | | |
As of December 31,
|
| |
As of June 30,
|
| ||||||||||||
| | | |
2021
|
| |
2020
|
| |
2022
|
| |||||||||
| | | |
($ in millions)
|
| |||||||||||||||
| Balance Sheet Data | | | | | | | | | | | | | | | | | | | |
|
Current assets of discontinued operations
|
| | | $ | 7,835 | | | | | $ | 6,841 | | | | | $ | — | | |
|
Total Current assets
|
| | | | 13,957 | | | | | | 12,562 | | | | | | 7,342 | | |
|
Property, plant and equipment (net of accumulated depreciation)
|
| | | | 64,558 | | | | | | 60,332 | | | | | | 66,456 | | |
|
Noncurrent regulatory assets
|
| | | | 8,224 | | | | | | 8,759 | | | | | | 8,350 | | |
|
Goodwill
|
| | | | 6,630 | | | | | | 6,630 | | | | | | 6,630 | | |
|
Investments
|
| | | | 250 | | | | | | 238 | | | | | | 235 | | |
|
Receivable related to Regulatory Agreement Units
|
| | | | — | | | | | | — | | | | | | 2,265 | | |
|
Other
|
| | | | 885 | | | | | | 1,143 | | | | | | 1,017 | | |
|
Property, plant and equipment, deferred debits and other assets of discontinued operations
|
| | | | 38,509 | | | | | | 39,653 | | | | | | — | | |
|
Total assets
|
| | | $ | 133,013 | | | | | $ | 129,317 | | | | | $ | 92,295 | | |
|
Current liabilities of discontinued operations
|
| | | | 7,940 | | | | | | 4,923 | | | | | | — | | |
|
Total current liabilities
|
| | | | 16,111 | | | | | | 12,771 | | | | | | 8,031 | | |
|
Long-term debt, including long-term debt to financing trusts
|
| | | | 31,139 | | | | | | 29,917 | | | | | | 36,179 | | |
|
Noncurrent regulatory liabilities
|
| | | | 9,628 | | | | | | 9,485 | | | | | | 8,513 | | |
|
Long-term debt, deferred credits and other liabilities of discontinued operations
|
| | | | 25,676 | | | | | | 26,345 | | | | | | — | | |
|
Total deferred credits and other liabilities
|
| | | | 50,968 | | | | | | 51,761 | | | | | | 24,429 | | |
|
Total equity
|
| | | | 34,795 | | | | | | 34,868 | | | | | | 23,656 | | |
|
Total liabilities and shareholders equity
|
| | | $ | 133,013 | | | | | $ | 129,317 | | | | | $ | 92,295 | | |
Offers
| | | |
As of June 30, 2022
|
| |||||||||
|
(in millions)
|
| |
Actual
|
| |
As Adjusted(a)
|
| ||||||
| Long-term debt: | | | | | | | | | | | | | |
|
Long-term debt, including long-term debt to financing trusts(b)
|
| | | $ | 36,684 | | | | | $ | 36,684 | | |
|
Original 2027 notes
|
| | | | 650 | | | | | | — | | |
|
Original 2032 notes
|
| | | | 650 | | | | | | — | | |
|
Original 2052 notes
|
| | | | 700 | | | | | | — | | |
|
Exchange 2027 notes offered hereby
|
| | | | — | | | | | | 650 | | |
|
Exchange 2032 notes offered hereby
|
| | | | — | | | | | | 650 | | |
|
Exchange 2052 notes offered hereby
|
| | | | — | | | | | | 700 | | |
|
Total equity
|
| | | | 23,656 | | | | | | 23,656 | | |
|
Total capitalization
|
| | | $ | 60,340 | | | | | $ | 60,340 | | |
c/o The Bank of New York Mellon
Corporate Trust Operations-Reorganization Unit
2001 Bryan Street, 10th Floor
Dallas, Texas 75201
Attn:
For Information Call:
Confirm by E-mail:
$650,000,000 aggregate principal amount of outstanding 2.750% Notes due 2027
(CUSIP Nos. 30161NAZ4 and US30161NAZ42)
for
$650,000,000 aggregate principal amount of newly issued 2.750% Notes due 2027 that will be issued in a transaction registered under the Securities Act of 1933, as amended (the “Securities Act”)
(CUSIP No. 30161NBB64)
and
$650,000,000 aggregate principal amount of outstanding 3.350% Notes due 2032
(CUSIP Nos. 30161NBC4 and US30161NBC48)
for
$650,000,000 aggregate principal amount of newly issued 3.350% Notes due 2032 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161NBE0)
and
$700,000,000 aggregate principal amount of outstanding 4.100% Notes due 2052
(CUSIP Nos. 30161NBF7 and US30161NBF78)
for
$700,000,000 aggregate principal amount of newly issued 4.100% Notes due 2052 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161BH35)
Senior Executive Vice President and Chief Financial Officer (Principal Financial Officer)
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ Christopher M. Crane
Christopher M. Crane
|
| |
President and Chief Executive Officer and Director
(Principal Executive Officer) |
| |
August 3, 2022
|
|
| |
/s/ Joseph R. Trpik
Joseph R. Trpik
|
| |
Senior Vice President and Corporate Controller
(Principal Accounting Officer) |
| |
August 3, 2022
|
|
| |
/s/ John F. Young
John F. Young
|
| | Director and Chairman | | |
August 3, 2022
|
|
| |
/s/ Anthony K. Anderson
Anthony K. Anderson
|
| | Director | | |
August 3, 2022
|
|
| |
/s/ Ann C. Berzin
Ann C. Berzin
|
| | Director | | |
August 3, 2022
|
|
| |
/s/ W. Paul Bowers
W. Paul Bowers
|
| | Director | | |
August 3, 2022
|
|
| |
/s/ Marjorie Rodgers Cheshire
Marjorie Rodgers Cheshire
|
| | Director | | |
August 3, 2022
|
|
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ Carlos Gutierrez
Carlos Gutierrez
|
| | Director | | |
August 3, 2022
|
|
| |
/s/ Linda Jojo
Linda Jojo
|
| | Director | | |
August 3, 2022
|
|
| |
/s/ Paul L. Joskow
Paul L. Joskow
|
| | Director | | |
August 3, 2022
|
|
Exhibit 5.1
August 3, 2022
Exelon Corporation
10 South Dearborn Street,
49th Floor,
Chicago, Illinois 60603-3005
| RE: | Registration Statement on Form S-4 |
Ladies and Gentlemen:
We have acted as counsel to Exelon Corporation (the “Company”), in connection with the exchange of: (i) up to $650,000,000 aggregate principal amount of the Company’s outstanding 2.750% Notes due 2027 (CUSIP Nos. 30161NAZ4 and US30161NAZ42) (the “original 2027 notes”) for a like principal amount of the Company’s 2.750% Notes due 2027 that will be issued in a transaction registered under the Securities Act (CUSIP No. 30161NBB64) (the “exchange 2027 notes”), (ii) up to $650,000,000 aggregate principal amount of the Company’s outstanding 3.350% Notes due 2032 (CUSIP Nos. 30161NBC4 and US30161NBC48) (the “original 2032 notes”) for a like principal amount of the Company’s 3.350% Notes due 2032 that will be issued in a transaction registered under the Securities Act (CUSIP No. 30161NBE0) (the “exchange 2032 notes”) and (iii) up to $700,000,000 aggregate principal amount of the Company’s outstanding 4.100% Notes due 2052 (CUSIP Nos. 30161NBF7 and US30161NBF78) (the “original 2052 notes” and, together with the original 2027 notes and the original 2032 notes, the “Original Notes”) for a like principal amount of the Company’s 4.100% Notes due 2052 that will be issued in a transaction registered under the Securities Act (CUSIP No. 30161BH35) (the “exchange 2052 notes” and, together with the exchange 2027 notes and the exchange 2032 notes, the “Exchange Notes” and, together with the Original Notes, the “Notes”). The Exchange Notes are covered by the Registration Statement on Form S-4, No. 333- (the “Registration Statement”), filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on August 30, 2019 under the Securities Act of 1933, as amended.
The Notes were issued under the terms of the Indenture, dated as of June 11, 2015 (the “Base Indenture”) between the Company and The Bank of New York Mellon Trust Company, N. A., as trustee (the “Trustee”), as supplemented and amended by the First Supplemental Indenture, dated as of June 11, 2015 (the “First Supplemental Indenture”), the Second Supplemental Indenture, dated as of December 2, 2015 (the “Second Supplemental Indenture”), the Third Supplemental Indenture, dated as of April 7, 2016 (the “Third Supplemental Indenture”), the Fourth Supplemental Indenture, dated as of April 1, 2020 (the “Fourth Supplemental Indenture”), and the Fifth Supplemental Indenture, dated as of March 7, 2022 (the “Fifth Supplemental Indenture” and, together with the First Supplemental Indenture, the Second Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture, and the Base Indenture, the “Indenture”), which Indenture is governed under the laws of the State of New York.
Exelon Corporation
August 3, 2022
Page 2
We have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement and all exhibits thereto, (ii) the Prospectus Supplement, (iii) the Amended and Restated Articles of Incorporation of the Company, and (iv) the Amended and Restated Bylaws of the Company. We have also examined such corporate records and other agreements, documents and instruments, such certificates or comparable documents of public officials and officers and representatives of the Company, have made such inquiries of such officers and representatives and have considered such matters of law as we have deemed appropriate as the basis for the opinions hereinafter set forth.
In delivering this opinion, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as certified, photostatic or conformed copies, the authenticity of originals of all such latter documents, and the accuracy and completeness of all records, information and statements submitted to us by officers and representatives of the Company. In making our examination of documents executed by parties other than the Company, we have assumed that such parties had the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization of all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof with respect to such parties.
Based upon and subject to the limitations and assumptions set forth herein, we are of the opinion that:
| 1. | The Company is a corporation duly organized and validly subsisting under the laws of the Commonwealth of Pennsylvania; and |
| 2. | When the Exchange Notes have been duly authorized, executed, and authenticated in accordance with the provisions of the Indenture, the Exchange Notes will be legally issued and binding obligations of the Company enforceable against the Company in accordance with their respective terms (except to the extent enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or other similar laws affecting the enforcement of creditors’ rights generally and by the effect of general principles of equity, regardless of whether considered in a proceeding in equity or at law). |
We express no opinion as to the law of any jurisdiction other than the Commonwealth of Pennsylvania and the federal laws of the United States.
We hereby consent to the filing of this letter as Exhibit 5.1 to the Registration Statement, and to the use therein of this firm’s name therein under the caption “Legal Matters.” In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.
Very truly yours,
/s/ Ballard Spahr LLP
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-4 of Exelon Corporation of our report dated February 25, 2022, except with respect to our opinion on the consolidated financial statements insofar as it relates to the effects of discontinued operations as discussed in Notes 1 and 2 and the change in composition of reportable segments as discussed in Note 5, as to which the date is June 30, 2022, relating to the financial statements, financial statement schedules and the effectiveness of internal control over financial reporting, which appears in Exelon Corporation's Current Report on Form 8-K dated June 30, 2022. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
| /s/ PricewaterhouseCoopers LLP | |
| Chicago, Illinois | |
| August 3, 2022 |
1
Exhibit 25.1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2) ¨|
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)
(Jurisdiction of incorporation if not a U.S. national bank) |
95-3571558 (I.R.S. employer identification no.) |
|
333 South Hope Street Los Angeles, California (Address of principal executive offices) |
90071 (Zip code) |
EXELON CORPORATION
(Exact name of obligor as specified in its charter)
| Pennsylvania (State or other jurisdiction of incorporation or organization) |
23-2990190 (I.R.S. employer identification no.) |
|
10 South Dearborn Street P.O. Box 805379 Chicago, Illinois |
60680-5379 (Zip code) |
2.750% Notes due 2027
3.350% Notes due 2032
and 4.100% Notes due 2052
(Title of the indenture securities)
| 1. | General information. Furnish the following information as to the trustee: |
| (a) | Name and address of each examining or supervising authority to which it is subject. |
| Name | Address |
| Comptroller of the Currency United States Department of the Treasury | Washington, DC 20219 |
| Federal Reserve Bank | San Francisco, CA 94105 |
| Federal Deposit Insurance Corporation | Washington, DC 20429 |
| (b) | Whether it is authorized to exercise corporate trust powers. |
Yes.
| 2. | Affiliations with Obligor. |
If the obligor is an affiliate of the trustee, describe each such affiliation.
None.
| 16. | List of Exhibits. |
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the "Act").
| 1. | A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A., formerly known as The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875). |
| 2. | A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948). |
| 3. | A copy of the authorization of the trustee to exercise corporate trust powers (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875). |
- 2 -
| 4. | A copy of the existing by-laws of the trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-229762). |
| 6. | The consent of the trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875). |
| 7. | A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority. |
- 3 -
SIGNATURE
Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Chicago and State of Illinois, on the 25th day of July, 2022.
| THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. | |||
| By: | /s/ | Ann Dolezal | |
| Name: | Ann Dolezal | ||
| Title: | Vice President | ||
- 4 -
EXHIBIT 7
Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 333 South Hope Street, Suite 2525, Los Angeles, CA 90071
At the close of business March 31, 2022, published in accordance with Federal regulatory authority instructions.
| Dollar amounts | ||||
| in thousands | ||||
| ASSETS | ||||
| Cash and balances due from depository institutions: | ||||
| Noninterest-bearing balances and currency and coin | 32,548 | |||
| Interest-bearing balances | 404,559 | |||
| Securities: | ||||
| Held-to-maturity securities | 0 | |||
| Available-for-sale debt securities | 50,736 | |||
| Equity securities with readily determinable fair values not held for trading | 0 | |||
| Federal funds sold and securities | ||||
| purchased under agreements to resell: | ||||
| Federal funds sold in domestic offices | 0 | |||
| Securities purchased under agreements to resell | 0 | |||
| Loans and lease financing receivables: | ||||
| Loans and leases held for sale | 0 | |||
| Loans and leases, held for investment | 0 | |||
| LESS: Allowance for loan and lease losses | 0 | |||
| Loans and leases held for investment, net of allowance | 0 | |||
| Trading assets | 0 | |||
| Premises and fixed assets (including capitalized leases) | 18,592 | |||
| Other real estate owned | 0 | |||
| Investments in unconsolidated subsidiaries and associated companies | 0 | |||
| Direct and indirect investments in real estate ventures | 0 | |||
| Intangible assets | 856,313 | |||
| Other assets | 88,428 | |||
| Total assets | $ | 1,451,176 | ||
| LIABILITIES | ||||
| Deposits: | ||||
| In domestic offices | 901 | |||
| Noninterest-bearing | 901 | |||
| Interest-bearing | 0 | |||
| Federal funds purchased and securities | ||||
| sold under agreements to repurchase: | ||||
| Federal funds purchased in domestic offices | 0 | |||
| Securities sold under agreements to repurchase | 0 | |||
| Trading liabilities | 0 | |||
| Other borrowed money: | ||||
| (includes mortgage indebtedness and obligations under capitalized leases) | 0 | |||
| Not applicable | ||||
| Not applicable | ||||
| Subordinated notes and debentures | 0 | |||
| Other liabilities | 274,081 | |||
| Total liabilities | 274,982 | |||
| Not applicable | ||||
| EQUITY CAPITAL | ||||
| Perpetual preferred stock and related surplus | 0 | |||
| Common stock | 1,000 | |||
| Surplus (exclude all surplus related to preferred stock) | 324,968 | |||
| Not available | ||||
| Retained earnings | 850,063 | |||
| Accumulated other comprehensive income | 163 | |||
| Other equity capital components | 0 | |||
| Not available | ||||
| Total bank equity capital | 1,176,194 | |||
| Noncontrolling (minority) interests in consolidated subsidiaries | 0 | |||
| Total equity capital | 1,176,194 | |||
| Total liabilities and equity capital | 1,451,176 | |||
1
I, Matthew J. McNulty, CFO of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.
Matthew J. McNulty ) CFO
We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.
| Antonio I. Portuondo, President | ) | |
| Michael P. Scott, Managing Director | ) | Directors (Trustees) |
| Kevin P. Caffrey, Managing Director | ) |
2
Relating to the
$650,000,000 aggregate principal amount of outstanding 2.750% Notes due 2027
(CUSIP Nos. 30161NAZ4 and US30161NAZ42)
for
$650,000,000 aggregate principal amount of newly issued 2.750% Notes due 2027 that will be issued in a transaction registered under the Securities Act of 1933, as amended (the “Securities Act”)
(CUSIP No. 30161NBB64)
and
$650,000,000 aggregate principal amount of outstanding 3.350% Notes due 2032
(CUSIP Nos. 30161NBC4 and US30161NBC48)
for
$650,000,000 aggregate principal amount of newly issued 3.350% Notes due 2032 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161NBE0)
and
$700,000,000 aggregate principal amount of outstanding 4.100% Notes due 2052
(CUSIP Nos. 30161NBF7 and US30161NBF78)
for
$700,000,000 aggregate principal amount of newly issued 4.100% Notes due 2052 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161BH35)
c/o The Bank of New York Mellon
Corporate Trust Operations-Reorganization Unit
2001 Bryan Street, 10th Floor
Dallas, Texas 75201
(732) 667-9408
Confirm by E-mail:
CT_REORG_UNIT_INQUIRIES@bnymellon.com
| | |
DESCRIPTION OF ORIGINAL NOTES
|
| | | 1 | | | | 2 | | | | 3 | | | | 4 | | | | 5 | | | | 6 | | | | 7 | | |
| | | Name(s) and Address(es) of Holder(s) (Please fill in, if blank) | | | |
Certificate Numbers*
|
| | | Aggregate Principal Amount of Original 2027 Notes | | | | Principal Amount of Original 2027 Notes Tendered** | | | | Aggregate Principal Amount of Original 2032 Notes | | | | Principal Amount of Original 2032 Notes Tendered*** | | | | Aggregate Principal Amount of Original 2052 Notes | | | | Principal Amount of Original 2052 Notes Tendered**** | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
*
Need not be completed if original notes are being tendered by book-entry transfer.
|
| | ||||||||||||||||||||||||||||
| | |
**
Unless otherwise indicated in this column, a holder will be deemed to have tendered ALL of the original 2027 notes represented by the original 2027 notes indicated in column 2. See Instruction 2. Original 2027 notes tendered hereby must be in denominations of principal amount of $2,000 and any integral multiples of $1,000 in excess thereof. See Instruction 1.
|
| | ||||||||||||||||||||||||||||
| | |
***
Unless otherwise indicated in this column, a holder will be deemed to have tendered ALL of the original 2032 notes represented by the original 2032 notes indicated in column 4. See Instruction 2. Original 2032 notes tendered hereby must be in denominations of principal amount of $2,000 and any integral multiples of $1,000 in excess thereof. See Instruction 1.
|
| | ||||||||||||||||||||||||||||
| | |
****
Unless otherwise indicated in this column, a holder will be deemed to have tendered ALL of the original 2052 notes represented by the original 2052 notes indicated in column 6. See Instruction 2. Original 2052 notes tendered hereby must be in denominations of principal amount of $2,000 and any integral multiples of $1,000 in excess thereof. See Instruction 1.
|
| | ||||||||||||||||||||||||||||
| |
Name of Tendering Institution:
|
| |||
| |
Account Number:
|
| |
Transaction Code Number:
|
|
| | |
SPECIAL ISSUANCE INSTRUCTIONS
(See Instructions 3 and 4)
To be completed ONLY if certificates for original notes not exchanged and/or exchange notes are to be issued in the name of and sent to someone other than the person(s) whose signature (s) appear(s) on this Letter of Transmittal above, or if original notes delivered by book-entry transfer that are not accepted for exchange are to be returned by credit to an account maintained at DTC other than the account indicated above.
Issue exchange notes and/or original notes to:
Name(s):
(Please Type or Print)
(Please Type or Print)
Address:
(Zip Code)
☐
Credit unexchanged original notes delivered by book-entry transfer to the DTC account set forth below.
(DTC Account Number, if applicable)
|
| | |
SPECIAL DELIVERY INSTRUCTIONS
(See Instructions 3 and 4)
To be completed ONLY if certificates for original notes not exchanged and/or exchange notes are to be sent to someone other than the person (s) whose signature(s) appear(s) on this Letter of Transmittal above or to such person(s) at an address other than shown in the box entitled “Description of Original Notes” on this Letter of Transmittal above.
Mail exchange notes and/or original notes to:
Name(s):
(Please Type or Print)
(Please Type or Print)
Address:
(Zip Code)
|
| |
CAREFULLY BEFORE COMPLETING ANY BOX ABOVE.
(TO BE COMPLETED BY ALL TENDERING HOLDERS)
| Area Code and Telephone Number: |
|
| Capacity: |
|
(If required by Instruction 3)
| by an Eligible Institution: |
|
Relating to the Offers to Exchange
(CUSIP Nos. 30161NAZ4 and US30161NAZ42)
for
$650,000,000 aggregate principal amount of newly issued 2.750% Notes due 2027 that will be issued in a transaction registered under the Securities Act of 1933, as amended (the “Securities Act”)
(CUSIP No. 30161NBB64)
and
$650,000,000 aggregate principal amount of outstanding 3.350% Notes due 2032
(CUSIP Nos. 30161NBC4 and US30161NBC48)
for
$650,000,000 aggregate principal amount of newly issued 3.350% Notes due 2032 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161NBE0)
and
$700,000,000 aggregate principal amount of outstanding 4.100% Notes due 2052
(CUSIP Nos. 30161NBF7 and US30161NBF78)
for
$700,000,000 aggregate principal amount of newly issued 4.100% Notes due 2052 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161BH35)
EXCHANGE AGENT
c/o The Bank of New York Mellon
Corporate Trust Operations-Reorganization Unit
2001 Bryan Street, 10th Floor
Dallas, Texas 75201
Attn:
Confirm by E-mail:
CT_REORG_UNIT_INQUIRIES@bnymellon.com
| | Certificate No(s). for Original Notes (if available): | | | Principal Amount of Original Notes Represented by Certificates: | |
| |
Principal Amount of Original Notes Tendered:
|
| |
Signature(s):
|
|
| |
Dated:
|
| |
If your original notes will be delivered by book-entry transfer at The Depository Trust Company, Depository Account No.:
|
|
| |
|
| |
|
|
| | This Notice of Guaranteed Delivery must be signed by the registered holder(s) of original notes exactly as its (their) name(s) appears on certificates of original notes or on a security position listing as the owner of original notes, or by person(s) authorized to become registered holder(s) by endorsements and documents transmitted with this Notice of Guaranteed Delivery. If signature is by a trustee, executor, administrator, guardian, attorney-in-fact, officer or other person acting in a fiduciary or representative capacity, such person must provide the following information: | | |||
| |
Name(s):
|
|
| |
Capacity:
|
|
| |
Address(es):
|
|
| |
Area Code and Telephone No.:
|
|
| |
Name of Firm
|
| |
Authorized Signature
|
|
| |
Address
|
| |
Title
|
|
| |
|
| |
Name:
|
|
| |
Zip Code
|
| |
(Please Type or Print)
|
|
| |
Area Code and Telephone No.:
|
| |
Dated:
|
|
DEPOSITORY TRUST COMPANY PARTICIPANTS
Relating to the Offers to Exchange
(CUSIP Nos. 30161NAZ4 and US30161NAZ42)
for
$650,000,000 aggregate principal amount of newly issued 2.750% Notes due 2027 that will be issued in a transaction registered under the Securities Act of 1933, as amended (the “Securities Act”)
(CUSIP No. 30161NBB64)
and
$650,000,000 aggregate principal amount of outstanding 3.350% Notes due 2032
(CUSIP Nos. 30161NBC4 and US30161NBC48)
for
$650,000,000 aggregate principal amount of newly issued 3.350% Notes due 2032 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161NBE0)
and
$700,000,000 aggregate principal amount of outstanding 4.100% Notes due 2052
(CUSIP Nos. 30161NBF7 and US30161NBF78)
for
$700,000,000 aggregate principal amount of newly issued 4.100% Notes due 2052 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161BH35)
(CUSIP Nos. 30161NAZ4 and US30161NAZ42)
for
$650,000,000 aggregate principal amount of newly issued 2.750% Notes due 2027 that will be issued in a transaction registered under the Securities Act of 1933, as amended (the “Securities Act”)
(CUSIP No. 30161NBB64)
and
$650,000,000 aggregate principal amount of outstanding 3.350% Notes due 2032
(CUSIP Nos. 30161NBC4 and US30161NBC48)
for
$650,000,000 aggregate principal amount of newly issued 3.350% Notes due 2032 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161NBE0)
and
$700,000,000 aggregate principal amount of outstanding 4.100% Notes due 2052
(CUSIP Nos. 30161NBF7 and US30161NBF78)
for
$700,000,000 aggregate principal amount of newly issued 4.100% Notes due 2052 that will be issued in a transaction registered under the Securities Act
(CUSIP No. 30161BH35)
BOOK-ENTRY TRANSFER PARTICIPANT
| |
Name of beneficial owner(s):
|
|
| |
Signature(s):
|
|
| |
Name(s) (please print):
|
|
| |
Address:
|
|
| |
Telephone Number:
|
|
| |
Taxpayer Identification or Social Security Number:
|
|
| |
Date:
|
|